Skip Navigation

Joel Blankson Lab

Joel Blankson, M.D., Ph.D.

Principal Investigator:
Joel Blankson, M.D., Ph.D.

Work in the Joel Blankson Lab explores the mechanism of control of HIV-1 replication in a cohort of patients known as elite controllers or elite suppressors. These patients are HIV-1 seropositive but maintain levels of viremia that are below the limit of detection of standard clinical assays. We feel that elite suppressors represent a potential model for a therapeutic HIV vaccine. Our central hypothesis is that many of these patients are infected with fully replication-competent HIV-1 isolates that are held in check by the immune system. To test this hypothesis, we are studying many different host and viral factors in these patients.

Research Areas: vaccines, infectious disease, HIV, pathogenesis, elite suppressors

Find a Research Lab
Edit lab profile

back to top button